Precision oncology: separating the wheat from the chaff

被引:31
作者
Remon, Jordi [1 ]
Dienstmann, Rodrigo [2 ]
机构
[1] HM Delfos, Ctr Integral Oncol Clara Campal Barcelona, Med Oncol Dept, Barcelona, Spain
[2] Hosp Valle De Hebron, Oncol Data Sci ODysSey Grp, Barcelona, Spain
关键词
CELL LUNG-CANCER; METASTATIC BREAST-CANCER; OPEN-LABEL; MOLECULAR CHARACTERIZATION; ANTICANCER DRUGS; TARGETED THERAPY; FDA APPROVAL; SOLID TUMORS; PHASE-II; MEDICINE;
D O I
10.1136/esmoopen-2018-000446
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Precision oncology based on next-generation sequencing (NGS) test is growing in daily clinical practice. However, the real impact of this strategy in patients' outcome on a large scale remains uncertain. In this review, we summarise existing literature on this topic, limitations for broad NGS implementation, bottlenecks in genomic variant interpretation and the role of molecular tumour boards.
引用
收藏
页数:7
相关论文
共 88 条
[31]   Implementing Genome-Driven Oncology [J].
Hyman, David M. ;
Taylor, Barry S. ;
Baselga, Jose .
CELL, 2017, 168 (04) :584-599
[32]   Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations [J].
Hyman, David M. ;
Puzanov, Igor ;
Subbiah, Vivek ;
Faris, Jason E. ;
Chau, Ian ;
Blay, Jean-Yves ;
Wolf, Juergen ;
Raje, Noopur S. ;
Diamond, Eli L. ;
Hollebecque, Antoine ;
Gervais, Radj ;
Elena Elez-Fernandez, Maria ;
Italiano, Antoine ;
Hofheinz, Ralf-Dieter ;
Hidalgo, Manuel ;
Chan, Emily ;
Schuler, Martin ;
Lasserre, Susan Frances ;
Makrutzki, Martina ;
Sirzen, Florin ;
Veronese, Maria Luisa ;
Tabernero, Josep ;
Baselga, Jose .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08) :726-736
[33]   Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer The SELECT-1 Randomized Clinical Trial [J].
Janne, Pasi A. ;
van den Heuvel, Michel M. ;
Barlesi, Fabrice ;
Cobo, Manuel ;
Mazieres, Julien ;
Crino, Lucio ;
Orlov, Sergey ;
Blackhall, Fiona ;
Wolf, Juergen ;
Garrido, Pilar ;
Poltoratskiy, Artem ;
Mariani, Gabriella ;
Ghiorghiu, Dana ;
Kilgour, Elaine ;
Smith, Paul ;
Kohlmann, Alexander ;
Carlile, David J. ;
Lawrence, David ;
Bowen, Karin ;
Vansteenkiste, Johan .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (18) :1844-1853
[34]   Combined Pan-HER and ALK/ROS1/MET Inhibition with Dacomitinib and Crizotinib in Advanced Non-Small Cell Lung Cancer: Results of a Phase I Study [J].
Janne, Pasi A. ;
Shaw, Alice T. ;
Camidge, D. Ross ;
Giaccone, Giuseppe ;
Shreeve, S. Martin ;
Tang, Yiyun ;
Goldberg, Zelanna ;
Martini, Jean-Francois ;
Xu, Huiping ;
James, Leonard R. ;
Solomon, Benjamin J. .
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (05) :737-747
[35]   Rogaratinib in patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression and effects of mutations in the FGFR signaling pathway. [J].
Joerger, Markus ;
Cassier, Philippe Alexandre ;
Penel, Nicolas ;
Cathomas, Richard ;
Richly, Heike ;
Schostak, Martin ;
Janitzky, Andreas ;
Wermke, Martin ;
Nogova, Lucia ;
Tai, David Wai-Meng ;
Sayehli, Cyrus ;
Grullich, Carsten ;
Grande, Enrique ;
Navarro, Alejandro ;
Park, Se Hoon ;
Nogai, Hendrik ;
Bender, Sebastian ;
Ellinghaus, Peter ;
Schuler, Martin H. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[36]   Clinical Use of Precision Oncology Decision Support [J].
Johnson, Amber ;
Khotskaya, Yekaterina B. ;
Brusco, Lauren ;
Zeng, Jia ;
Holla, Vijaykumar ;
Bailey, Ann M. ;
Litzenburger, Beate C. ;
Sanchez, Nora S. ;
Abu Shufean, Md ;
Piha-Paul, Sarina ;
Subbiah, Vivek ;
Hong, David ;
Routbort, Mark ;
Broaddus, Russell ;
Shaw, Kenna R. Mills ;
Mills, Gordon B. ;
Mendelsohn, John ;
Meric-Bernstam, Funda .
JCO PRECISION ONCOLOGY, 2017, 1 :1-12
[37]   Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing Panel [J].
Johnson, Douglas B. ;
Dahlman, Kimberly H. ;
Knol, Jared ;
Gilbert, Jill ;
Puzanov, Igor ;
Means-Powell, Julie ;
Balko, Justin M. ;
Lovly, Christine M. ;
Murphy, Barbara A. ;
Goff, Laura W. ;
Abramson, Vandana G. ;
Crispens, Marta A. ;
Mayer, Ingrid A. ;
Berlin, Jordan D. ;
Horn, Leora ;
Keedy, Vicki L. ;
Reddy, Nishitha M. ;
Arteaga, Carlos L. ;
Sosman, Jeffrey A. ;
Pao, William .
ONCOLOGIST, 2014, 19 (06) :616-622
[38]   Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies [J].
Jordan, Emmet J. ;
Kim, Hyunjae R. ;
Arcila, Maria E. ;
Barron, David ;
Chakravarty, Debyani ;
Gao, JianJiong ;
Chang, Matthew T. ;
Ni, Andy ;
Kundra, Ritika ;
Jonsson, Philip ;
Jayakumaran, Gowtham ;
Gao, Sizhi Paul ;
Johnsen, Hannah C. ;
Hanrahan, Aphrothiti J. ;
Zehir, Ahmet ;
Rekhtman, Natasha ;
Ginsberg, Michelle S. ;
Li, Bob T. ;
Yu, Helena A. ;
Paik, Paul K. ;
Drilon, Alexander ;
Hellmann, Matthew D. ;
Reales, Dalicia N. ;
Benayed, Ryma ;
Rusch, Valerie W. ;
Kris, Mark G. ;
Chaft, Jamie E. ;
Baselga, Jose ;
Taylor, Barry S. ;
Schultz, Nikolaus ;
Rudin, Charles M. ;
Hyman, David M. ;
Berger, Michael F. ;
Solit, David B. ;
Ladanyi, Marc ;
Riely, Gregory J. .
CANCER DISCOVERY, 2017, 7 (06) :596-609
[39]   Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation [J].
Kaufman, Bella ;
Shapira-Frommer, Ronnie ;
Schmutzler, Rita K. ;
Audeh, M. William ;
Friedlander, Michael ;
Balmana, Judith ;
Mitchell, Gillian ;
Fried, Georgeta ;
Stemmer, Salomon M. ;
Hubert, Ayala ;
Rosengarten, Ora ;
Steiner, Mariana ;
Loman, Niklas ;
Bowen, Karin ;
Fielding, Anitra ;
Domchek, Susan M. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03) :244-250
[40]   Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience [J].
Knepper, Todd C. ;
Bell, Gillian C. ;
Hicks, J. Kevin ;
Padron, Eric ;
Teer, Jamie K. ;
Vo, Teresa T. ;
Gillis, Nancy K. ;
Mason, Neil T. ;
McLeod, Howard L. ;
Walko, Christine M. .
ONCOLOGIST, 2017, 22 (02) :144-151